Product Information
LAMIVUDINE 150 MG TABLET is a generic product labeled by Apotex Corp., priced at $0.4602 per EA under NDC 60505325106. Its NADAC has been published 636 times since Nov 28, 2013.
Strength
150 mg/1
Manufacturer
Apotex Corp.NDC
60505325106
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LAMIVUDINEApproval Type
Generic (ANDA)
FDA Application
ANDA091606On Market Since
12/2/2011
Pharmacological Classes
Price Statistics
The NADAC for LAMIVUDINE 150 MG TABLET has been published 636 times since Nov 28, 2013, and over the history we have for it it has declined 89.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4602 per EA |
|---|---|
| All-time high | $4.4389 (Jun 11, 2014) |
| All-time low | $0.4126 (Oct 22, 2025) |
| 52-week high | $0.5088 |
| 52-week low | $0.4126 |
| Median price | $1.0173 |
| Average price | $1.5027 |
| Largest weekly change | +54.1% (May 22, 2019) |
| Weeks tracked | 636 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LAMIVUDINE 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMIVUDINE 150 MG TABLET, manufactured by Apotex Corp., is $0.4602 per EA (NDC 60505325106), effective Jun 24, 2026.
How has the price of LAMIVUDINE 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for LAMIVUDINE 150 MG TABLET has declined 89.5%. It has been tracked across 636 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LAMIVUDINE 150 MG TABLET?
Since Nov 28, 2013, the NADAC for LAMIVUDINE 150 MG TABLET has ranged from a low of $0.4126 (Oct 22, 2025) to a high of $4.4389 (Jun 11, 2014), with a median of $1.0173 per EA.
Are there cheaper alternatives to LAMIVUDINE 150 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as LAMIVUDINE 150 MG TABLET, but none are currently priced below it.
Who manufactures LAMIVUDINE 150 MG TABLET?
LAMIVUDINE 150 MG TABLET (NDC 60505325106) is labeled by Apotex Corp., and CMS classifies it as a generic product.
Related Drugs
Same classification